Cargando…

WHO's Response to Global Public Health Threats: XDR-TB

Detalles Bibliográficos
Autores principales:	Wilson, Kumanan, Gardam, Michael, McDougall, Christopher, Attaran, Amir, Upshur, Ross
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950212/ https://www.ncbi.nlm.nih.gov/pubmed/17676989 http://dx.doi.org/10.1371/journal.pmed.0040246

Ejemplares similares

XDR-TB in South Africa: No Time for Denial or Complacency
por: Singh, Jerome Amir, et al.
Publicado: (2007)

XDR-TB in South Africa: Back to TB Sanatoria Perhaps?
por: Sakoane, Ramalitse
Publicado: (2007)

XDR-TB in South Africa: Revised Definition
por: Holtz, Timothy H
Publicado: (2007)

XDR-TB in South Africa: Detention Is Not the Priority
por: Goemaere, Eric, et al.
Publicado: (2007)

XDR-TB in South Africa: Theory and Practice
por: Andrews, Jason, et al.
Publicado: (2007)

The New International Health Regulations and the Federalism Dilemma
por: Wilson, Kumanan, et al.
Publicado: (2006)

Extensively drug resistant tuberculosis (XDR-TB): A potential threat
por: Marwar, Anaga, et al.
Publicado: (2010)

Extensively Drug-Resistant Tuberculosis (XDR-TB) - A Potential Threat in Ireland
por: Mc Laughlin, Anne Marie, et al.
Publicado: (2007)

XDR Tuberculosis: A Looming Threat
por: Sharma, Vishal, et al.
Publicado: (2009)

MDR and XDR typhoid fever-a threat for the current decade?
por: Pustake, Manas, et al.
Publicado: (2021)

Florona: An emerging threat posing alarming risks to global public health and possible containment measures
por: Islam, Fahadul, et al.
Publicado: (2022)

Global plagues and the Global Fund: Challenges in the fight against HIV, TB and malaria
por: Tan, Darrell HS, et al.
Publicado: (2003)

Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use
por: Hafkin, Jeffrey, et al.
Publicado: (2017)

Global health and its discontents
por: Rasanathan, Kumanan
Publicado: (2021)

Why and How the Old Neuroleptic Thioridazine Cures the XDR-TB Patient
por: Amaral, Leonard, et al.
Publicado: (2012)

The Ebola Vaccine, Iatrogenic Injuries, and Legal Liability
por: Attaran, Amir, et al.
Publicado: (2015)

Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now
por: Chowdhury, Kona, et al.
Publicado: (2023)

How Is WHO Responding to Global Public Health Threats?
Publicado: (2007)

Early detection of Pre-XDR TB with line probe assay in a high TB burden country
por: Madukaji, Laura, et al.
Publicado: (2021)

You can’t report your feelings: The hidden labor of managing threats to safety by women in global public health fieldwork
por: McAuliffe, Corey, et al.
Publicado: (2022)

Adherence to HAART: Africans Take Medicines More Faithfully than North Americans
por: Attaran, Amir
Publicado: (2007)

Threats of evictions in the USA: A public health concern
por: Aborode, Abdullahi Tunde
Publicado: (2022)

Risk Factors for MDR and XDR-TB in a Tertiary Referral Hospital in India
por: Balaji, V., et al.
Publicado: (2010)

Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China
por: Pang, Yu, et al.
Publicado: (2016)

War against COVID-19: looming threat of XDR typhoid battle in Pakistan
por: Tanveer, M., et al.
Publicado: (2021)

The rapid spreading of monkeypox virus is a threat for global public health: What should we do to fight this old enemy?
por: Akter, Mst. Sarmin, et al.
Publicado: (2022)

Re-emerges yellow fever infections: potential threat for global public health, present status, diagnosis, and future perspective – correspondence
por: Akash, Shopnil, et al.
Publicado: (2023)

Artificial tears: Promising treatment or silent threat to public health?
por: Mughal, Sanila, et al.
Publicado: (2023)

Monkeypox: A global threat to domestic and wild animals – Correspondence
por: K. C, Nikhil, et al.
Publicado: (2022)

Risk Factors for Poor Treatment Outcomes in Patients with MDR-TB and XDR-TB in China: Retrospective Multi-Center Investigation
por: Tang, Shenjie, et al.
Publicado: (2013)

Survival from XDR-TB Is Associated with Modifiable Clinical Characteristics in Rural South Africa
por: Shenoi, Sheela V., et al.
Publicado: (2012)

Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
por: Metcalfe, John, et al.
Publicado: (2019)

Monkeypox as an emerging global health threat during the COVID- 19 time
por: Mukherjee, Dattatreya, et al.
Publicado: (2022)

Predictive factors for unfavourable treatment in MDR-TB and XDR-TB patients in Rio de Janeiro State, Brazil, 2000-2016
por: Bhering, Marcela, et al.
Publicado: (2019)

Legionella pneumonia as a rising public health threat in Argentina: Is it the time to worry?
por: Malik, Sumira, et al.
Publicado: (2022)

Successful use of prolonged cefiderocol monotherapy for the treatment of a complex pleural abscess caused by extensively drug-resistant (XDR) Pseudomonas aeruginosa
por: Brookfield, Charlotte, et al.
Publicado: (2023)

Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand
por: Sowajassatakul, Angkanang, et al.
Publicado: (2014)

First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB
por: Lewis, Joseph M., et al.
Publicado: (2016)

XDR-TB Transmitted from Mother to 10-Month-Old Infant: Diagnostic and Therapeutic Problems
por: Kozińska, Monika, et al.
Publicado: (2022)

Clinical and socio-economic characteristics of a cohort of MDR/XDR TB patients in Bucharest, Romania
por: Ivanova, O, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a8qf481j1si8d846efrk2pk7ev